KRO · Kronos Worldwide Inc
Price & Indicators
Up next
Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders BuyIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from its earnings releases, calls, and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| EBITDA non-GAAP | $27.7M | first quarter of 2026 | — |
|
|
|||
| TiO2 segment profit non-GAAP | $15.1M | first quarter of 2026 | — |
| Production facilities capacity utilization | 55% | fourth quarter of 2025 | — |
|
|
|||
| Production facilities overall average capacity utilization | 77% | full year of 2025 | — |
| TiO2 segment loss non-GAAP | -$22.2M | full year of 2025 | — |
Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file
Versus peers
Specialty Chemicals — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
KRO
this stock
Kronos Worldwide Inc
|
$760.50M | +51.6% | -1.5% | — | 1.2% |
|
LIN
Linde PLC
|
$236.98B | +19.1% | +3.0% | 34.0 | 1.4% |
|
AIQUF
L Air Liquide SA /Fi
|
$128.41B | +6.9% | — | — | 0.0% |
|
SHW
Sherwin Williams Co
|
$78.31B | -3.7% | +26.4% | 30.5 | 2.7% |
|
ECL
Ecolab Inc.
|
$75.64B | +0.5% | +2.2% | 36.4 | 1.2% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| KRO | -0.6% | +1.2% | +24.6% | +4.9% | +51.6% |
| SPY | -1.7% | +0.7% | +6.4% | -1.2% | +8.3% |
| vs SPY | +1.1% | +0.6% | +18.2% | +6.1% | +43.4% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.